HomeGRI • NASDAQ
GRI Bio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.95M | -3.55% |
Net income | -1.95M | 2.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.95M | 3.56% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.03M | 178.10% |
Total assets | 5.74M | 94.15% |
Total liabilities | 1.71M | -36.71% |
Total equity | 4.03M | — |
Shares outstanding | 525.36K | — |
Price to book | 0.18 | — |
Return on assets | -87.25% | — |
Return on capital | -123.02% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.95M | 2.79% |
Cash from operations | -2.00M | 64.05% |
Cash from investing | — | — |
Cash from financing | 2.28M | -41.21% |
Net change in cash | 282.00K | 116.79% |
Free cash flow | -1.27M | -29.76% |
Previous close
$1.40
Day range
$1.33 - $1.44
Year range
$1.21 - $130.39
Market cap
701.35K USD
Avg Volume
576.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2009
Headquarters
Website
Employees
3
